iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mangalam Drugs and Organics standalone net profit declines 32.13% in the June 2022 quarter

5 Aug 2022 , 05:45 PM

Net profit of Mangalam Drugs and Organics declined 32.13% to Rs 3.00 crore in the quarter ended June 2022 as against Rs 4.42 crore during the previous quarter ended June 2021. Sales rose 2.79% to Rs 107.70 crore in the quarter ended June 2022 as against Rs 104.78 crore during the previous quarter ended June 2021.

Particulars Quarter Ended
? Jun. 2022 Jun. 2021 % Var.
Sales 107.70 104.78 3
OPM % 9.62 9.88
PBDT 6.83 7.91 -14
PBT 4.23 5.52 -23
NP 3.00 4.42 -32

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.